High-content assessment of Pseudomonas aeruginosa bacteriophage efficacy reveals host genetic factors involved in phage specificity

Ellward, G. L.; Bucher, M. J.; Zhai, Y.; Munguia, N. S.; Marini, S.; Marsella, R.; Bisesi, J. H.; Montazeri, N.; Cherabuddi, K.; Jeong, K. C.; Czyz, D. M.

doi:10.1101/2025.04.03.646983

bioRxiv · 10.1101/2025.04.03.646983

High-content assessment of Pseudomonas aeruginosa bacteriophage efficacy reveals host genetic factors involved in phage specificity

Ellward, G. L.·Bucher, M. J.·Zhai, Y.·Munguia, N. S.·Marini, S.·Marsella, R.·Bisesi, J. H.·Montazeri, N.·Cherabuddi, K.·Jeong, K. C.·Czyz, D. M.

View original source ↗Export metadata ↓

Abstract

Pseudomonas aeruginosa infects immunocompromised and hospitalized individuals, resulting in over 500,000 annual deaths. With emerging multidrug resistance and stagnating antibiotic development, alternative antimicrobials are desperately needed. Bacteriophages (phages) offer a promising, effective, and safe alternative. We developed and optimized a high-content liquid assay screen and a stringent assessment of efficacy to isolate and characterize seven novel P. aeruginosa phages. Phages were screened individually and in cocktail, inhibiting the growth of over 90% (50/55) of multidrug-resistant clinical strains and [~]75% (102/137) of animal, environmental, and human isolates. When tested in a mouse bacteremia model, the phage cocktail successfully eradicated P. aeruginosa. A proteome-wide bi-directional BLAST identified eight proteins that influenced phage infection. The functional analysis of the corresponding genes reveals their putative roles involving genome modification and transcriptional regulation, metabolic processes, and structural components essential for phage docking. Collectively, we have developed a rigorous high-content approach to identify effective phages, which, coupled with functional genomics, revealed genes that affect phage-bacteria interaction. Author SummaryIn this study, we explored the potential of bacteriophages (phages) isolated from municipal and hospital wastewater sources for combating multidrug-resistant Pseudomonas aeruginosa, an opportunistic pathogen known for posing significant clinical challenges. A rigorous stepwise screen aimed at enhancing specificity against a broad set of 55 clinical P. aeruginosa strains allowed us to isolate diverse class phages that can target over 90% of the clinical isolates. Our phage efficacy assessments employed a colorimetric MTT assay to measure the metabolic activity of P. aeruginosa strains in response to phage exposure. Notably, the phages demonstrated broad coverage against the P. aeruginosa library, with individual phages showing varying degrees of efficacy and a cocktail exhibiting superior inhibitory properties. Further validation using a mouse bacteremia model confirmed the exceptional efficacy of the cocktail, supported by a complete attenuation of clinical signs of infection and a significant reduction of bacterial loads across all organs, supporting their utility as potential phage therapy. Finally, a comprehensive comparative genomic analysis of target bacteria combined with phage efficacy revealed novel genes that are potentially involved in phage infection. These findings provide a foundation for understanding phage-host interactions and pave the way for the development of targeted phage therapies against antibiotic-resistant bacterial infections.

Explore related subjects

microbiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Ellward, G. L., Bucher, M. J., Zhai, Y., Munguia, N. S., Marini, S., Marsella, R., Bisesi, J. H., Montazeri, N., Cherabuddi, K., Jeong, K. C., Czyz, D. M.. 2025-04-03. High-content assessment of Pseudomonas aeruginosa bacteriophage efficacy reveals host genetic factors involved in phage specificity. https://doi.org/10.1101/2025.04.03.646983

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Reverse Transcription Loop-Mediated Isothermal Amplification Combined with Lateral Flow Assay (RT-LAMP-LFA) for Rapid Detection of the 2026 Bundibugyo Virus (BDBV) Outbreak Strain

Making accurate diagnosis is a critical first step in patient management and control for emerging and re-emerging disease outbreaks. Bundibugyo virus (BDBV) is a filovirus that causes Ebola disease, and the 2026 outbreak highlights the need for rapid diagnostic approaches that can be deployed in settings with limited laboratory infrastructure. Here, we developed a reverse transcription loop-mediated isothermal amplification-lateral flow assay (RT-LAMP-LFA) for rapid detection of the 2026 BDBV outbreak strain. LAMP primers were designed based on the genome sequence of the 2026 outbreak strain, and the conservation of the primer binding sites among all available 2026 outbreak genomes was confirmed in silico. LAMP primers were evaluated for analytical specificity and sensitivity using in vitro-transcribed RNA (ivtRNA) from BDBV and other filoviruses, as well as RNA derived from arboviruses and mammalian cells. Amplification products were detected using a Chromatography-Printed Array Strip (C-PAS) lateral flow platform. The newly designed primers specifically detected the presence of BDBV RNA without nonspecific amplification of the other viral or cellular RNA samples tested. Consistent amplification was observed down to 103 copies per reaction. In addition, BDBV viral RNA was successfully amplified, and the amplification products were detected using C-PAS, with the total workflow being completed within 25 min. These findings demonstrate the analytical specificity and sensitivity of the developed RT-LAMP-LFA assay and its compatibility with rapid visual lateral flow detection, supporting its potential application as a point-of-care approach for BDBV detection.

microbiology↗

bioRxiv2026

Divergent methane production and microbial community responses to carbon enrichment in freshwater wetland sediments

Methane (CH4) accumulation in wetland sediments reflects interactions among organic matter, sediment chemistry, and microbial communities. We combined depth-resolved field characterization across four wetland habitats in northern Israel with complementary incubations to examine methane accumulation and responses to labile-carbon enrichment. Sediment cores were characterized using Rock-Eval analysis, porewater chemistry, oxygen profiling at three sites, and mcrA amplicon sequencing. High CH4 concentrations occurred under contrasting conditions: Ein Nimfit (EN) contained approximately 12% total organic carbon and reached 2.1 mM CH4, whereas Ein Afek site EA2 contained approximately 5% carbon and accumulated 0.7-1.7 mM CH4. Both showed sulfate depletion, but EN exhibited pronounced sulfide accumulation, whereas EA2 showed greater dissolved iron and nutrient enrichment. Their classified methanogenic assemblages also differed. EA1 remained methane poor despite increasing carbon content with depth, while EA3 combined low carbon content and CH4 accumulation with detectable methanogens and lower methanogenic diversity. In a 36-day bottle experiments using sediments from two of the four wetland habitats, sucrose-amended EA3 exhibited a transient maximum of 18.8 mmol collected CH4 kg-1 wet sediment during Days 22-29, whereas EN reached its highest collected amount during Days 29-36. Methane proportions increased before the large output increase in EA3 but remained comparatively stable and high in EN. Soluble chemical oxygen demand trajectories and microbial community changes also differed. These findings identify distinct biogeochemical settings supporting methane accumulation and demonstrate methanogenic potential in low-CH4 sediment, emphasizing the complementary information provided by field profiles, microbial characterization, and exploratory enrichment experiments.

microbiology↗

bioRxiv2026

The absence of microbiome in germ-free mice exacerbates the pathogenicity of mouse-adapted SARS-CoV-2 MA10

Germ-free mice, which are devoid of microbiota, provide a powerful system to define the contribution of the microbiome to host responses during infection. Severe COVID-19 outcomes are associated with multiple comorbidities that are themselves characterized by microbiome dysbiosis; however, the causal role of the microbiota in SARS-CoV-2 pathogenesis remains poorly understood. Here, we use germ-free mouse models to evaluate the impact of the microbiome on disease severity following infection with mouse-adapted SARS-CoV-2 MA10. Comparison with conventionally housed mice revealed that the absence of the microbiome markedly exacerbates SARS-CoV-2-induced disease in both C57BL/6 and Swiss Webster backgrounds. Germ-free mice exhibited greater weight loss, impaired lung function, worsened pulmonary pathology, and pronounced alterations in circulating cytokine and chemokine profiles compared with conventional controls. These findings show that resident microbiota limit SARS-CoV-2 pathogenicity and establish germ-free COVID-19 models as a powerful platform to identify protective microbial taxa and microbiota-based interventions to reduce severe disease.

microbiology↗